Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Total Valuation
Globus Medical has a market cap or net worth of $11.61B. The enterprise value is $11.20B.
Market Cap$11.61B
Enterprise Value$11.20B
Share Statistics
Globus Medical has 137.54M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding137.54M
Owned by Insiders16.45%
Owned by Instutions0.69%
Financial Efficiency
Globus Medical’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 3.21%.
Return on Equity (ROE)2.47%
Return on Assets (ROA)1.96%
Return on Invested Capital (ROIC)3.21%
Return on Capital Employed (ROCE)3.78%
Revenue Per Employee$475,350
Profits Per Employee$19,430.943
Employee Count5,300
Asset Turnover0.48
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of Globus Medical is 109.01. Globus Medical’s PEG ratio is -3.60.
PE Ratio109.01
PS Ratio4.46
PB Ratio2.69
Price to Fair Value2.69
Price to FCF27.70
Price to Operating Cash Flow21.56
PEG Ratio-3.60
Income Statement
In the last 12 months, Globus Medical had revenue of $2.52B and earned $102.98M in profits. Earnings per share was $0.75.
Revenue$2.52B
Gross Profit$1.39B
Operating Income$214.62M
Pretax Income$120.72M
Net Income$102.98M
EBITDA513.19M
Earnings Per Share (EPS)0.75
Cash Flow
In the last 12 months, operating cash flow was $520.64M and capital expenditures -$115.43M, giving a free cash flow of $405.21M billion.
Operating Cash Flow$520.64M
Free Cash Flow$405.21M
Free Cash Flow per Share$2.95
Dividends & Yields
Globus Medical pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield3.61%
Earnings Yield0.92%
Stock Price Statistics
Beta0.89
52-Week Price Change40.08%
50-Day Moving Average78.20
200-Day Moving Average76.88
Relative Strength Index (RSI)47.06
Average Volume (3m)1.40M
Important Dates
Globus Medical upcoming earnings date is May 13, 2025, After Close.
Last Earnings DateFeb 20, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
Globus Medical as a current ratio of 2.54, with Debt / Equity ratio of 0.13
Current Ratio2.54
Quick Ratio1.77
Debt to Market Cap0.05
Net Debt to EBITDA-0.52
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Globus Medical has paid $17.74M in taxes.
Income Tax$17.74M
Effective Tax Rate14.69%
Enterprise Valuation
Globus Medical EV to EBITDA ratio is 23.18, with an EV/FCF ratio of 27.09.
EV to Sales4.36
EV to EBITDA23.18
EV to Free Cash Flow27.09
EV to Operating Cash Flow21.09
Balance Sheet
Globus Medical has $890.06M in cash and marketable securities with $537.19M in debt, giving a net cash position of -$352.87M billion.
Cash & Marketable Securities$890.06M
Total Debt$537.19M
Net Cash-$352.87M
Net Cash Per Share-$2.57
Tangible Book Value Per Share$14.37
Margins
Gross margin is 58.90%, with operating margin of 6.59%, and net profit margin of 4.09%.
Gross Margin58.90%
Operating Margin6.59%
Pretax Margin4.79%
Net Profit Margin4.09%
EBITDA Margin18.80%
EBIT Margin8.72%
Analyst Forecast
The average price target for Globus Medical is $98.58, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$98.58
Price Target Upside35.80%
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast60.62%
EPS Growth Forecast-35.88%